Sartorius Stedim Biotech SA

FR

STDMX

Health Care

21.3 ₽

Current price

Strong sell
21.3 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    174 / 240

  • Position in country

    703 / 834

  • Return on Assets, %

    5.7

    -2.7

  • Debt to Equity, %

    139.5

    15.1

  • Intangible assets and goodwill, %

    59.2

    4.7

  • Revenue CAGR 3Y, %

    13.2

    12.8

  • Total Equity change 1Y, %

    11

    -2.4

  • Revenue Y, % chg

    -18.1

    0

  • P/E

    74.5

    32.1

  • P/BV

    8.7

    2

  • P/S

    8.7

    4.1

  • EV/S

    10

    3.6

  • EV/EBITDA

    35.6

    7.8

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    926.4

    48.9

  • Forward P/E

    49.7

    25.5

  • Dividend Yield, %

    0.2

    0.8

  • Forward Dividend Yield, %

    4

    0.2

  • Expected dividend per share

    1.1

    0

  • Dividend Ex Date

    2024-04-02

Get an analytical review of this company

Competitors

Ranks

  • Lonza Group AG

    00%

  • Samsung Biologics Co Ltd

    00%

  • IQVIA Holdings Inc

    00%

  • West Pharmaceutical Services Inc

    00%

  • Agilent Technologies Inc

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Waters Corp

    00%

  • Mettler-Toledo International Inc

    00%

  • Sartorius Stedim Biotech SA

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    France

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    26156.8

  • Ticker

    SRTOY.PK

  • ISIN

    US80386Y1010

  • IPO date

    1994-10-20

  • Availability on Russian exchanges

    No

  • Reporting for

  • Date fact. publication of reports

Company Description

Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The Company operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: